The Oasis of Hope Approach
Our philosophy is to work with, not against, conventional medicine. For many patients, our therapies are designed to complement ongoing care, improving outcomes and overall well-being.
Supportive Integrative Care During Chemotherapy
- Therapies to reduce side effects such as nausea, fatigue, and infection risk
- Immune support to protect against opportunistic infections
- Nutritional and metabolic interventions to promote resilience and recovery
Potentiation of Conventional Therapy
- High-dose Vitamin C, curcumin, and ozone therapy to increase tumor cell sensitivity to chemotherapy
- Metabolic therapies that disrupt cancer cell energy production, enhancing drug effectiveness
Advanced Immunotherapy – The ImPACT Program
At Oasis of Hope, leukemia patients have access to our signature ImPACT Immunotherapy Program (Immune Personalized Autologous Cell Therapy) — a next-generation immune restoration approach that uses the patient’s own immune cells to fight leukemia throughout the bloodstream and bone marrow.
Our cGMP-certified and ISO-accredited laboratory produces personalized immune cell therapies for each patient, ensuring precision, safety, and efficacy.
Adoptive Immune Cell Therapy (NK, T-Cells, and LAK Cells)
- Natural Killer (NK) cells and Lymphokine-Activated Killer (LAK) cells are expanded into the billions and activated to improve their cancer-fighting capabilities.
- Upon reinfusion, they circulate systemically, targeting circulating leukemia cells and diseased marrow while strengthening immune function.
Co-Activated Cell Therapy
Many leukemia patients receive Co-Activated Cell Therapy, a core component of the ImPACT Program, in which Dendritic Cells and LAK Cells are combined in one infusion.
This dual-cell strategy provides both immediate leukemia-killing activity and long-term immune memory, helping reduce relapse and maintain remission.
Hematology Oversight & Specialized Studies
Every leukemia patient at Oasis of Hope is evaluated and monitored by a board-certified hematologist. We perform specialized hematological studies — including bone marrow, immune marker, and cytokine analysis — to guide therapy design, track immune recovery, and optimize treatment response.
This close hematologic collaboration ensures that every immunotherapy and metabolic protocol is scientifically guided and precisely monitored.